Oncoplastic approach in the conservative treatment of breast cancer: analysis of costs
Oncoplastic approach in the conservative treatment of breast cancer: analysis of costs
复制标题
DOI：
10.1590/s0102-86502012000500006
复制
发表时间：
2012-05-01
期刊：
影响因子：
--
通讯作者：
Ferreira, Lydia Masako
中科院分区：
文献类型：
--
作者：
Lima, Débora Eleotério de;Veiga Filho, Joel;Ferreira, Lydia Masako
目的：分析在巴西国立卫生保健公共系统（SUS）的一所大学医院进行的乳腺癌保守手术治疗的直接费用，检查肿瘤整形方法对这些费用的影响。方法：选取2005 ~ 2010年接受过或未接受过肿瘤增生入路保守治疗的乳腺癌患者138例（n=36）（对照组，n=102）。记录社会人口学和临床数据。获得并分析了手术的直接费用。结果：组间年龄差异无统计学意义（p=0.963），肿瘤组患者住院时间较长（p=0.000）。肿瘤组的直接费用中位数为461.00雷亚尔，对照组为229.00雷亚尔（p=0.000）。结论：肿瘤成形术在保守性乳腺癌手术治疗中产生了较高的直接费用。
PURPOSE: To analyze the direct costs of conservative surgical treatment of breast cancer, performed in a university hospital, to the Brazilian National Health Care Public System (SUS), checking the impact of the oncoplastic approach on these costs.METHODS: One hundred thirty eight breast cancer patients who had undergone conservative treatment with oncoplastic approach (n=36) or not (control group, n=102), in the period from 2005 to 2010, were enrolled. Sociodemographic and clinical data were recorded. The direct costs of the surgical procedure were obtained and analyzed.RESULTS: Groups did not differ in regard to age (p=0.963), and patients in oncoplastic group had a longer time of hospital stay (p=0.000). The median direct cost for the oncoplastic group was R$461.00 and for the control group was R$229.00 (p=0.000).CONCLUSION: The oncoplastic approach has generated higher direct costs in conservative surgical treatment of breast cancer to SUS.